April New Deal Reads
JAK–STAT pathway targeting for the treatment of inflammatory bowel disease. [...]
March New Deal Reads
Lipid-based nanoformulations in the treatment of neurological disorders. Pottoo et [...]
February New Deal Reads
Efficacy and Safety of Upadacitinib in a Randomized Trial of [...]
September New Deal Reads
1. siRNA Delivery for Control of Cyclin D1 and E2F1 [...]
August New Deal Reads
1. Inside out: optimization of lipid nanoparticle formulations for exterior [...]
May New Deal Reads
A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation [...]
April New Deal Reads
1. Targeting JAK-STAT signal transduction in IBD. Soendergaard C. et al. Pharmacology [...]
February New Deal Reads
In New Deal Reads we have prepared for you a [...]
